Berberine, a bioactive alkaloid, shows promise in Alzheimer’s disease (AD) treatment due to its neuroprotective effects, including acetylcholinesterase inhibition, antioxidative activity, and Aβ reduction. This evidence concerns the gene ACHE and Alzheimer disease.